Fig. 6. Comparison of dexlansoprazole modified-release (MR) and esomeprazole delayed-release (DR). (A) Mean plasma concentration-time curves of dexlansoprazole and esomeprazole after single oral doses of dexlansoprazole MR 60 mg and esomeprazole 40 mg DR capsule in healthy subjects. (B) Mean intragastric pH from 0 to 24 hours postdose after single oral doses of dexlansoprazole MR 60 mg (open square) and esomeprazole 40 mg DR capsule (closed circle). Adapted from Kukulka et al.
59
